Globally, breast cancer (BC) is the leading cancer type in women, and approximately three‐quarters of all BCs are estrogen receptor (ER) and/or progesterone receptor (PR) positive (Provenzano, Ulaner, & Chin, 2018; Waks & Winer, 2019). This evidence concerns the gene PGR and breast carcinoma.